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Abstract. 
 
There are conflicting views on whether col-
lagen X is a purely structural molecule, or regulates 
bone mineralization during endochondral ossification. 
Mutations in the human collagen 
 
a
 
1(X) gene 
(
 
COL10A1
 
) in Schmid metaphyseal chondrodysplasia 
(SMCD) suggest a supportive role. But mouse collagen 
 
a
 
1(X) gene (
 
Col10a1
 
) null mutants were previously re-
ported to show no obvious phenotypic change. We have 
generated collagen X deficient mice, which shows that 
deficiency does have phenotypic consequences which 
partly resemble SMCD, such as abnormal trabecular 
bone architecture. In particular, the mutant mice de-
velop 
 
coxa vara
 
, a phenotypic change common in hu-
man SMCD. Other consequences of the mutation are 
reduction in thickness of growth plate resting zone and 
articular cartilage, altered bone content, and atypical 
distribution of matrix components within growth plate 
cartilage. We propose that collagen X plays a role in 
the normal distribution of matrix vesicles and pro-
teoglycans within the growth plate matrix. Collagen X 
deficiency impacts on the supporting properties of the 
growth plate and the mineralization process, resulting 
in abnormal trabecular bone. This hypothesis would ac-
commodate the previously conflicting views of the 
function of collagen X and of the molecular pathogene-
sis of SMCD.
E
 
ndochondral
 
 ossification is the major process
leading to the formation and growth of most of the
skeleton in vertebrates during skeletogenesis. This
process involves gradual replacement of the primordial
cartilaginous model in the growth plate by bony tissue
through temporally and spatially coordinated differentia-
tion, growth, and remodeling events of chondrocyte prolif-
eration, maturation, and hypertrophy. During the final
stages of this process, calcification of hypertrophic carti-
lage occurs, vasculature invades, and bone matrix is depos-
ited, replacing the cartilaginous matrix at the chondro-
osseous junction of the growth plate (Iannotti, 1990).
Collagen X is a homotrimer of three 
 
a
 
1(X) chains, with
a short (38 aa) nonhelical amino terminus (NC2), a triple
helix of 463 aa and a COOH-terminal highly conserved
noncollagenous domain (NC1) of 161 aa. This collagen is
the major extracellular component synthesized by hyper-
trophic chondrocytes in growth cartilage destined to be
calcified and in zones of secondary ossification (Mayne
and Irwin, 1986; Schmid and Linsenmayer, 1987). Expres-
sion of the 
 
a
 
1(X) collagen gene is specifically associated
with hypertrophic chondrocytes and precedes the onset of
endochondral ossification (Kong et al., 1993). Although
this collagen does not form fibrils, it has been found as fine
pericellular filaments in association with cartilage collagen
fibrils (Schmid and Linsenmayer, 1990). Collagen X mole-
cules may also form other supramolecular structures in the
matrix, since they have been shown to assemble into a hex-
agonal lattice in vitro (Kwan et al., 1991).
Apart from association with collagen fibrils, collagen X
interacts with other matrix components, such as annexin V,
chondrocalcin (Kirsch and Pfäffle, 1992) and proteogly-
cans (Chen et al., 1992). Collagen X has been shown to en-
hance accumulation of proteoglycans when it infiltrates
into nonhypertrophic cartilage (Chen et al., 1992). Col-
lagen X has also been shown to be intimately associated
with the calcification process by binding to Ca
 
11
 
 and ma-
trix vesicles, which are cell-derived microstructures found
in the matrix of calcifying cartilage and bone and thought
to be important in the initiation of mineral deposition
(Anderson, 1989). In addition, the expression of collagen
X precedes mineral deposition by cultured chondrocytes
(Kirsch et al., 1992).
Despite the wealth of information about collagen X, the
precise function of this protein and its role in the patho-
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genesis of chondrodysplasia, has remained the subject of
controversy. Because of its specific association with hyper-
trophic chondrocytes in the calcifying zone of growth plate
cartilage, collagen X has been proposed to be important
for endochondral bone formation (Schmid and Linsen-
mayer, 1987). Proposed functions include, providing an
easily resorbed fabric for the deposition of bone matrix
during endochondral growth of long bones; providing sup-
port as the cartilage matrix is degraded during endochon-
dral ossification (Gibson et al., 1986; Schmid and Linsen-
mayer, 1985); or regulating the calcification process during
endochondral ossification (Bonen and Schmid, 1991; Schmid
et al., 1991; Poole and Pidoux, 1989; Schmid et al., 1990).
Reconciling these different views has also been difficult
because the consequence of gene mutations which result
in collagen X deficiency in human and mouse are contra-
dictory.
Mutations in the NC1 encoding domain of the human
 
a
 
1(X) collagen gene (
 
COL10A1
 
) have been found to be
associated with the autosomal dominant inherited skeletal
disorder, Schmid metaphyseal chondrodysplasia (SMCD)
 
1
 
(Warman et al., 1993; Wallis et al., 1994; Wallis, 1993;
McIntosh et al., 1995). SMCD is a relatively mild form of
metaphyseal chondrodyplasia, resulting from growth plate
abnormalities. The SMCD phenotype is variable in sever-
ity and characterized by short to normal stature, with 
 
genu
varum
 
 (bow legs), 
 
coxa vara
 
 (a reduced angle between the
femoral neck and shaft), and flaring of the metaphyses of
long bone (Lachman et al., 1988; Horton and Hecht, 1993).
Transgenic mice expressing truncated chicken collagen X,
display much more severe skeletal abnormalities, similar
to human spondylometaphyseal dysplasia (SMD) (Jacenko
et al., 1993
 
b
 
), in which there is reduced thickness of the hy-
pertrophic zone of the growth plate and a decrease in
newly formed bony trabeculae.
Since collagen 
 
a
 
 chains associate via the NC1 domain, it
has been proposed that in human SMCD, the NC1 muta-
tions result in failure of trimer assembly (Warman et al.,
1993; Wallis et al., 1994) and the phenotypic changes are
caused because collagen X is depleted in the matrix. This
proposal is supported by recent reports that collagen
 
a
 
1(X) chains carrying SMCD mutations are unable to
form trimers in in vitro assembly and cell transfection ex-
periments (Chan et al., 1995, 1996). In the SMD transgenic
mice, the chondrodysplasia is postulated to be caused by a
depletion of collagen X as a result of instability/degrada-
tion of mutant chicken-mouse hybrid protein or because
the chicken 
 
a
 
 chains interfere with the normal assembly of
mouse collagen X.
Haploinsufficiency for collagen X as the cause of SMCD
would be consistent with a supportive role for this protein
(Warman et al., 1993; Wallis et al., 1994; Jacenko et al.,
1993
 
a
 
). Therefore it was suprising to find that mice carry-
ing a null mutation in the 
 
a
 
1(X) collagen gene (
 
Col10a1
 
)
have been reported to show no abnormality and no signs
of SMCD (Rosati et al., 1994). This finding suggests that
collagen X does not play a structural role by providing
support in the growth plate.
To gain insight into the function of collagen X, we have
created a null mutation in mouse 
 
Col10a1
 
 by homologous
recombination in ES cells. To resolve the apparently con-
tradictory consequences of mutations in the gene of human
and mouse and gain better insight into the pathogenesis of
SMCD, we have focused our study on the consequences of
collagen X deficiency on the structure of the growth plate
and trabecular bone, and on the organization of matrix
components within cartilage.
In this study we have found that collagen X deficiency
does have phenotypic consequences in mice. Some of the
abnormalities partly resemble those found for human
SMCD. Our data help address issues raised by the appar-
ent discrepancy in phenotype between human and mouse
and in addition, reveal insight into the function of collagen
X. Based on the present findings, we propose that collagen
X plays a role in the normal distribution of the cartilage
matrix components within the growth plate. Deficiency of
this collagen impacts on the supporting properties of the
growth plate and the mass of newly formed trabecular
bone, resulting in abnormal bone architecture.
 
Materials and Methods
 
Production of Collagen X Deficient Mice
 
A replacement gene targeting vector was generated from a cosmid clone
containing the 
 
Col10a1
 
 gene (Kong et al., 1993) isolated from a 129Sv
mouse genomic library (Fig. 1 
 
A
 
). It contained 7.6 kb of 
 
Col10a1
 
 sequence
extending from 1.6 kb upstream of exon 1 to a HindIII site within exon 3;
a neomycin resistance expression cassette (PGKneo, with the mouse 
 
Pgk-1
 
gene promoter and polyadenylation site), inserted in reverse transcrip-
tional orientation into EcoRI site of exon 3 (encodes the helical and
COOH-terminal noncollagenous domains of the 
 
a
 
1(X) collagen chain);
and a herpes simplex virus thymidine kinase (tk) expression cassette
(MC1tkpA) immediately 3
 
9
 
, to enrich for homologous recombinants by
negative selection in FIAU. Targeted mutation of 
 
Col10a1
 
 would there-
fore result in a new BglII site and multiple stop codons in the coding re-
gion for the triple helix. The targeting vector DNA (25 
 
m
 
g) was linearized
at a unique SalI site adjacent to the tk cassette and electroporated into 10
 
7
 
CCE ES cells (a gift of Dr. E. Robertson, Harvard University, Boston,
MA) at 240V/500 
 
m
 
F using a gene pulser (Bio-Rad Labs., Hercules, CA).
Recombinants were then double-selected by culturing in media containing
400 
 
m
 
g/ml G418 (GIBCO-BRL, Gaithersburg, MD) and 0.2 
 
m
 
M FIAU
(Bristol-Myers Squibb, Wallingford, CT). Clones (480) were analyzed by
HindIII digestion of genomic DNA and Southern hybridization to an in-
ternal 1.2-kb EcoRI-HindIII probe (Fig. 1 
 
A
 
) which hybridizes to a 4.9-kb
or a 3.3-kb fragment in the mutant and wild-type alleles, respectively. Cor-
rect targeting was confirmed using a 3
 
9
 
 probe (634 bp HindIII fragment)
external to the targeted region, which hybridizes to two BglII fragments,
2.8 kb and 3.2 kb, in mutant instead of 6.0 kb and 3.2 kb in wild-type alleles
(Fig. 1, 
 
A
 
 and 
 
B
 
). Targeted ES clones were microinjected into C57BL/6
blastocysts to generate chimeras to obtain germline transmission. Germ-
line chimeras were subsequently bred with both C57BL/6 and 129/SvJ fe-
males to produce mouse lines of C57BL/6-129/SvJ hybrid and pure 129/
SvJ background, respectively. F1 agouti offspring carrying the 
 
Col10a1
 
mutation were identified by Southern analysis on tail DNA using both in-
ternal and external probes. Heterozygous 
 
Col10a1
 
1
 
/
 
2
 
 F1 progeny were
mated to produce F2 litters containing homozygous null mutants (Fig. 1 
 
B
 
).
 
Reverse-Transcription PCR Assays
 
Total cartilage RNA was isolated from 2-d mice by the lithium chloride/
urea method (Lovell-Badge, 1987). Reverse-transcription (RT)-PCR as-
says on cartilage RNA from 2-d mice, carried out as described previously
(Kong et al., 1993), were used to determine if any wild-type 
 
Col10a1
 
mRNA was transcribed from the mutant allele using primers specific to
the sequence 3
 
9
 
 and 5
 
9
 
 to the PGKneo insert (Fig. 1 
 
A
 
, primer C [5
 
9
 
-
ATACCTTCTCGTCCTTGCTT-3
 
9
 
] and primer A [5
 
9
 
-ACACAAAG-
GAGATATTGGCC-3
 
9
 
]) to yield an expected product of 417 bp. The
 
1. 
 
Abbreviations used in this paper
 
: RHT, ruthenium hexammine trichlo-
ride; SCMD, Schmid metaphyseal chondrodysplasia; SMD, spondylo-
metaphyseal dysplasia.
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presence of mutant transcript was detected using primers C and B (5
 
9
 
-
AGGGGAGGAGTAGAAGGTGG-3
 
9
 
) located within the PGKneo in-
sert (Fig. 1 
 
A
 
) to give an expected product of 535 bp. Control reactions
without reverse transcriptase were done in parallel. The 1.2-kb EcoRI–
HindIII fragment (Fig. 1 
 
A
 
, 
 
crossed box
 
) was used as a probe in Southern
analyses to confirm that the resulting DNA bands corresponded to the
wild-type and mutant 
 
Col10a1
 
 cDNA, respectively. PCR products ampli-
fied from DNA of wild-type and targeted ES cell clones using the two
pairs of primers were used as an additional marker to confirm the sizes of
the resulting RT-PCR products.
 
Immunohistochemistry, Morphometry, and
Statistical Analyses
 
For immunostaining, 6-
 
m
 
m cryostat sections of Tissue-Tek OCT-embed-
ded hindlimbs from 2-d mice were fixed in ice-cold 5% glacial acetic acid/
95% ethanol and digested with testicular hyaluronidase (0.2% in PBS, Sigma
type IV-S) for 30 min at room temperature. Specimens were treated with
rabbit polyclonal antibody (diluted 1:500 in PBS/3%BSA, pH 7.2) against
bacterially expressed COOH-terminal noncollagenous peptide of mouse
collagen X (Pfordte, T., and B.R. Olsen, unpublished data) and the fluo-
rescein isothiocyanate-conjugated goat anti-rabbit Ig (Southern Biotech-
nology Associates, Inc., Birmingham, AL; diluted 1:80 in PBS/3%BSA
with 5% normal mouse serum). For histology, hindlimbs of 2-d, 4-wk, and
8-wk-old mice were fixed in 4% paraformaldehyde in PBS (pH 7.2). Sam-
ples from 2-d mice were processed without demineralization, but 4-wk and
8-wk samples were decalcified in 15% formic acid/0.5 M sodium formate.
Specimens were embedded in Histo-resin (Jung). Sections (4 
 
m
 
m) were
cut and stained with toluidene blue.
Morphometric measurement of the thickness of different zones of the
growth plate and the articular cartilage was performed on sections (4 
 
m
 
m)
of the limb stained with toluidine blue. Only sections in comparable longi-
tudinal planes along the proximal-distal axis of the femur were chosen for
morphometry. Camera lucida drawings of the distal region of the bone
were made. The thickness of the zones, the numbers of trabeculae in the
chondro-osseous junction, and columns of chondrocytes in the proliferat-
ing zone was determined by analyzing images captured by an ultrasonic
digitizer (Grafbar) using a Stereometry program (Yucomp). Since sample
sizes (
 
n
 
 
 
5
 
 5–12) were relatively small, nonparametric comparison between
groups of data was performed using Kolmogorov-Smirnov (K-S) test
which examines if the distribution of the data was the same between geno-
types. This test is sensitive to difference in median, dispersion, skewness
between data sets but is not subject to any bias in ranking order. A two-
tailed probability of 
 
,
 
0.05 is taken to indicate significant difference in
morphometric values between genotypes.
 
In Situ Hybridization
 
The expression of genes for several matrix molecules in the hindlimb of 2-d
mutant mice of both genetic backgrounds was studied by in situ hybridiza-
tion as previously described (Cheah et al., 1991). In brief, the tissues to be
analyzed were fixed in 4% paraformaldehyde in PBS for 16 h at 4
 
8
 
C and
embedded in paraffin and sectioned at 6 
 
m
 
m. Slides with sections were de-
waxed and hybridized to [
 
35
 
S]UTP-labeled RNA probes. Probes used
were for: (
 
a
 
) collagens and matrix molecules normally expressed in carti-
lage: collagens 
 
a
 
1(II), 
 
a
 
1(IX), 
 
a
 
1(X), 
 
a
 
2(XI) (Cheah et al., 1991, 1995;
Kong et al., 1993) 
 
a
 
1(VI), 
 
a
 
2(VI) (gifts of M.L. Chu, Thomas Jefferson
University, Philadelphia, PA), osteonectin (gift of M. Kurkkinen, Wayne
State University, Detroit, Michigan), aggrecan, link protein (gifts of Y.
Yamada, National Institutes of Health, Bethesda, MD); and (
 
b
 
) for matrix
molecules not normally expressed in cartilage: collagens 
 
a
 
(I), 
 
a
 
1(VIII),
 
a
 
2(VIII), and fibrillin (a gift of F. Ramirez, Mount Sinai School of Medi-
cine, New York, NY). Hybridization, washing and RNase treatment fol-
lowed as described (Cheah et al., 1991). Slides were dipped in emulsion
(Ilford) and exposed for 2–20 d before developing.
 
Electron Microscopy
 
A total of eight mice, four mutant (
 
2
 
/
 
2
 
), and four wild-type (
 
1
 
/
 
1
 
) were
studied. After sacrifice, tissues were immediately fixed in 5% glutaralde-
hyde, 2% paraformaldehyde with 0.05% ruthenium hexammine trichlo-
ride (RHT) in 0.1 M sodium cacodylate buffer (pH 7.3) for 6 h at 4
 
8
 
C and
then rinsed in cacodylate buffer. After postfixation in 1% osmium tetrox-
ide for 1 h, tissues were washed with buffer, dehydrated in ethanol, and
then cleared in propylene oxide and embedded in resin. Ultrathin sections
were produced using Reichert Ultracut S ultramicrotome and stained with
uranium acetate and lead citrate. Sections were examined on a JEOL
JEM-100 electron microscope operated at 80 kV. In addition samples
from 3 
 
2
 
/
 
2
 
 and 3 
 
1
 
/
 
1
 
 mice were fixed in tannic acid containing fixative
as described (Rosati et al., 1994), instead of RHT and processed for elec-
tron microscopy.
 
Quantitation of Proteoglycans and Matrix Vesicles
 
The density of proteoglycan material (at a magnification of 50,000) in the
upper hypertrophic zones of three wild-type and three mutant mice were
measured by scoring the number of those proteoglycan granules and com-
plexes touching a grid of 200 nm 
 
3
 
 200 nm in a total tissue area of 3.2 
 
m
 
m
 
2
Figure 1. Targeted disruption of the Col10a1 gene. (A) Targeting
strategy and recombinant mutant allele of Col10a-1. Neomycin
resistance (neo) and HSV-thymidine kinase (tk) genes (spotted
boxes) with arrows indicating the direction of transcription. Re-
striction sites: B, BglII; E, EcoRI; H, HindIII. Solid boxes, exons
of the gene; numerals above those boxes are exon numbers;
crossed box, internal probe; hatched box, 39 external probe; gray
box, probe for in-situ hybridization; arrowheads A, B, and C
show positions of primers used for RT-PCR analyses which re-
vealed low levels of mutant transcripts in heterozygotes and homo-
zygotes but no wild-type mRNAs in 2/2 mice. (B) Left, South-
ern analysis of representative ES cell clones by using 39 external
probe showing the 2.8 kb BglII fragment diagnostic of the mutant
allele in targeted ES cell clones (clones 1, 2, 4, 5 ; 1/2) and 6.0 kb
BglII fragment being characteristic of wild-type allele (clone 3;
1/1 and CCE) while the 3.2 kb BglII fragment is common for
both wild-type and mutant alleles. Right, Southern analysis of tail
biopsies of F2 mice from heterozygous cross by using internal
probe showing the 4.9-kb HindIII fragment which is diagnostic of
the mutant allele present in heterozygous (1/2) and homozygous
(2/2) mutants but absent in wild-type (1/1) mice.
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in five different fields. The number of matrix vesicles in a tissue unit vol-
ume of 0.32 mm3 (magnification of 50, 000) were counted in seven mutant
and seven wild-type mice (see Table II). The data were assessed for statis-
tical significance by the two-tailed Mann-Whitney U test.
Radiological and Mineral Density Analyses
Contact X-ray microradiographs of 2-d and 4-wk intact limbs, fixed in 4%
paraformaldehyde in PBS (pH 7.2), were taken using the Softex X-ray
machine (Softex ISO-20, Japan) with ultra-high resolution photographic
film (Kodak Spectro-photographic film). This method yields high resolution
X-ray images but could not be used on larger bones from mice older than
4-wk. The exposure for 2-d samples was 5 min at 18 kV/3 mA and for 4-wk
samples was 10 min at 18 kV/5 mA. X-ray images were captured digitally
into a microcomputer using a light microscope equipped with a 3-CCD vi-
deo camera (JVC-3800, Japan). Mineral density was computed using Im-
age 1.7 software (Macintosh) and statistical analyses of the data computed
by K-S test as for the morphometric measurements. A two-tailed proba-
bility of ,0.05 is taken to indicate a significant difference in density values
between genotypes.
Radiological images of older animals were taken under identical exposure
and radiation energy (24 kV/25 mA) using high resolution Kodak mammog-
raphy X-ray film (Kodak Diagnostic film Min-RTMH MRH-1) and a General
Electric X-ray machine (Senograph 600T Senix HF, General Electric). Mice
Figure 2. Col10a1 mutant mice lacking collagen X. (A) RT-PCR analyses revealed no wild-type Col10a1 mRNA transcript in the mu-
tant mice (2/2) by using primers A & C (left panel); mutant Col10a1 transcript was detected from heterozygous (1/2) and homozygous
(2/2) by using primers B & C (right panel) but not from wildtype (1/1). 1RT, with reverse transcriptase; 2RT, without reverse tran-
scriptase. TC, targeted ES cell clone DNA; CCE, wild-type ES cells DNA for PCR only as control for size. (B and C) Dark-field views
of in situ hybridization on 2-d wild-type (B) and mutant (C) mice proximal tibia growth plate using a1(X) probe (see Fig. 1). A very low
level of mutant Col10a1 transcript was detected in mutant. Abbreviations: pro, proliferating chondrocytes; uhy, upper hypertrophic
chondrocytes; lhy, lower hypertrophic chondrocytes. Bar, 200 mm. (D and F) Immunostaining of the growth plate cartilage of the proxi-
mal tibia of wild-type (D) and null mutant (F) show no detectable collagen X in the mutants but presence of the protein in the hyper-
trophic zone and cartilaginous remnants in bony trabeculae of wild type. (E and G) Phase contrast pictures of a region shown in D and
F, respectively. Abbreviations: pro, proliferating zone; hy, hypertrophic zone; bm, bone matrix. Bar, 200 mm.
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were briefly narcotized to facilitate radiography. To guard against artefact
due to variation in positioning of the femur while taking X rays, a consistent
position of the legs were maintained as far as possible and only comparable
images in which the trochanter could be seen, were measured.
Results
Generation of Collagen X Deficient Mice
The mouse a1(X) collagen gene (Col10a1) spans 7.0 kb of
DNA and contains three exons. Exons 2 and 3 together
encode the entire translated sequence, with the triple heli-
cal and NC1 domains encoded within exon 3. To generate
a null allele of Col10a1, a targeting vector was constructed
that would generate a mutant allele with an exon 3, dis-
rupted in the beginning of the helix encoding domain, and
also containing multiple premature stop codons (Fig. 1 A).
Eight targeted clones were identified by Southern blot
hybridization using both internal and 39 external probes
(Fig. 1 B), at a frequency of 2% in G418 and FIAU-double
resistance clones. Four targeted clones were used for gen-
eration of chimeric mice and two of them contributed to
the germline (Fig. 1 B). Chimeras from two of these inde-
pendently derived ES clones were subsequently bred with
both C57BL/6 and 129/SvJ females to produce mouse lines of
C57BL/6-129/SvJ hybrid and pure 129/SvJ background, re-
spectively, in order to assess any difference in the pheno-
type of different genetic backgrounds. Heterozygous F1
Col10a11/2 appeared normal and were bred to produce
homozygous F2 Col10a12/2 (hereafter termed mutant)
which appeared superficially similar to wild type. Approx-
imately 25% of F2 offspring were homozygous null mu-
tants which could survive up to 2 years of age.
To assess if the mutant mice were truly deficient in col-
lagen X, RT-PCR assays were used to determine if wild-
type Col10a1 mRNA was present using primers specific to
sequences 39 and 59 to the PGKneo insert. No wild-type
Col10a1 transcript was detected in cartilage RNA (Fig. 2
A) in the mutant, although low levels of mutant Col10a1
mRNAs were present (Fig. 2, B and C). The NC1 domain
of collagen X has been shown to be important for trimer
assembly (Chan et al., 1995). Cell transfection studies have
shown that unassembled collagen X chains cannot be se-
creted and are degraded intracellularly (Chan et al., 1996).
Therefore, any protein produced from mutant transcript
would consist of the 38-aa NC2 domain only and probably
would not be secreted to the matrix. Immunohistochemis-
try performed on the growth cartilage of 2-d-old mutant
neonates showed absence of collagen X protein (Fig. 2,
D–G) confirming the mice were deficient in the protein.
We tested for altered transcriptional activity for genes
encoding eight other collagens and other matrix compo-
nents which may have compensated for collagen X defi-
ciency. These included genes for collagen a1(VIII) and
a2(VIII) which are not normally expressed in cartilage but
are structurally similar to collagen X (Muragaki et al.,
1991a, b) and components not normally present in carti-
lage such as collagen a1(I) and fibrillin. In addition, en-
hanced expression of other genes expressed in cartilage
such as collagens a1(II), a1(VI), a2(VI), a1(IX), a2(XI),
Figure 3. Unaltered transcriptional activity of other genes in the growth plate of collagen X mutants. In situ hybridization of proximal
tibia growth plates of 129/SvJ 2-d-old wild-type (1/1, A–F) and mutant (2/2, G–L) mice showing expression of collagens a1(II) (A and
G); a2(VI) (B and H); a1(VIII) (C and I); a2(VIII) (D and J); a1(IX) (E and K); and link protein (F and L). All pictures are dark-field
views showing sections hybridized with corresponding matrix molecules antisense RNA probes. There is no alteration in the expres-
sion of these genes in the mutant mice compared with the wild type. Abbreviations: res, resting chondrocytes; pro, proliferating chon-
drocytes; hy, hypertrophic chondrocytes. Bar, 200 mm.
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osteonectin, aggrecan, and link protein was tested. In situ
hybridization assays showed no changes in the distribution
or levels of expression of those mRNAs in the growth
plates of heterozygous or homozygous null mutant mice
(Fig. 3 and data not shown).
Alterations in the Growth Plate and Trabecular Bone of 
Col10a1 Deficient Mice
The cellular development and overall architecture of growth
plate cartilage of the femurs of 2-d and 4-wk-old mutant
mice of two genetic backgrounds (C57BL/6-129/SvJ hy-
brid and 129/SvJ) appeared unchanged. However, detailed
morphometric analyses revealed a 18–25% reduction in
the height of the resting zone of chondrocytes in the epi-
physeal growth plates in 2-d mutants of both genetic back-
grounds (Table I). C57BL/6-129/SvJ hybrid 4-wk mutants
showed a 17% reduction (P , 0.05 by K-S test) in articular
cartilage thickness but there was less difference between
mutant and wild-type in 4-wk 129/SvJ mice (Table I).
Histological analyses were made in four mutants and four
wild-type mice at 2 d, 4 wk, and 8 wk. These analyses of the
metaphyseal growth plate of the tibia of mutant mice have re-
vealed alteration in the architecture of the trabecular bone at
the chondro-osseous junction. In the 2-d 129Sv/J mutant, a
more compact trabecular zone was found. There was also a
reduced amount of bony material in the trabeculae and the
bone marrow space was also reduced. There was, however,
no obvious change in the cellularity of the marrow, except for
a higher packing density of the marrow cells (Fig. 4, A and
B). A compact trabecular region was still evident in 4-wk mu-
tants (Fig. 4, C and D) and the amount of toluidine blue
stained material in the trabeculae was similar between the
mutant and wild-type tibia. By 8 wk, the trabeculae of wild-
type mice had formed extensive ramifications and contained
a much higher content of toluidine blue materials when com-
pared with the mutant (Fig. 4, E and F). These morphological
differences between wild-type and mutant mice were consis-
tently found in the mice (four of each genotype) studied.
However, such differences were less obvious in C57BL/6-129/
SvJ hybrid mutant mice (data not shown).
Ultrastructural Abnormalities
To preserve the hydrated state of chondrocytes and stabi-
lize macromolecular interactions between the plasma mem-
brane and pericellular proteoglycans, thereby allowing
better retention of matrix macromolecules, samples were
fixed for electron microscopy in ruthenium hexammine
trichloride (RHT) (Hunziker et al., 1982). Ultrastructural
analyses revealed major changes in the distribution and
organization of growth plate matrix materials. In 2-d-old
null mutants of 129/SvJ background, there was a striking
increased amount of matrix vesicles in the resting and pro-
liferating zones of growth plate cartilage (Fig. 5, A a–f; Ta-
ble II). Such matrix vesicles were absent in these zones of
the wild-type mice and were normally found in the upper
hypertrophic and maturing zones. In the mutant, there was
a significant reduction in the quantity of the matrix vesi-
cles in the upper hypertrophic zone of the growth plate
cartilage (Fig. 5, A g and h; Table II). A similar pattern of
abnormal distribution of proteoglycan-like material was
also found. In the resting and proliferating zones of the
mutant cartilage, the concentration of proteoglycan-like
materials was markedly increased (Fig. 5 A d and f) but
was reduced in the upper hypertrophic zone (Fig. 5 A i and j).
Scoring measurements of the amount of proteoglycan
granular material in the upper hypertrophic zone showed
that there was a significant reduction in mutants compared
with wild-type (two-tailed P value ,0.05 by Mann-Whit-
ney U test: mutant, 50.4 6 2.2; wild type, 122.8 6 22.0). Al-
though the structure of collagen fibrils in the resting zone
of wild-type and mutants were comparable (Fig. 5 A a–d),
fibrils were organized differently in the proliferative and
upper hypertrophic zones (Fig. 5 A e–h) which may be a
consequence of the changed interactions between pro-
teoglycans and other matrix components with the collagen
fibrils. These differences were less pronounced in the
Table I. Growth Plate Measurements in Collagen X Deficient and Wild-Type Mice
Zone
2 d pp
C011Oa-1 genotype
129Sv (n) C57/BL6-129/SvJ (n)
1/1 (8) 2/2 (6) 1/1 (10) 2/2 (12)
Resting 80.1 6 1.5 65.8 6 3.7* 71.1 6 4.2 52.8 6 4.3*
Proliferating 1 maturing 964.2 6 23.3 999.2 6 37.29 871.5 6 46.6 800.7 6 47.3
Hypertrophic 167.7 6 5.3 187.5 6 16.97 176.2 6 12.4 173.0 6 7.9
Total plate thickness 1211.0 6 25.13 1252.5 6 26.9 1118.8 6 39.8 1026.5 6 44.9
Width of plate 693.4 6 39.5 749.2 6 49.5 659.9 6 43.5 666.5 6 29.0
Number of columns 18.8 6 1.3 19.6 6 1.2 18.2 6 1.2 17.7 6 0.7
Number of trabeculae 19.6 6 1.2 17.3 6 0.7 16.4 6 1.2 14.3 6 0.9
4 wk 1/1 (10) 2/2 (9) 1/1 (6) 2/2 (11)
Articular cartilage 95.5 6 11.9 77.5 6 5.3 61.7 6 4.3 51.5 6 2.7*
Maturing 205.8 6 11.0 184.2 6 13.8 148.9 6 6.1 147.9 6 4.2
Hypertrophic 119.9 6 8.7 108.5 6 7.9 112.8 6 8.4 110.0 6 6.8
Total plate thickness 325.8 6 14.1 292.7 6 20.1 323.3 6 14.8 309.4 6 10.4
Number of trabeculae 18.30 6 2.96 16.43 6 0.90 19.33 6 1.58 19.36 6 0.65
A two-tailed probability of , 0.05 (denoted by *) by K-S test, is taken to indicate a significant difference in morphometric values between genotype. Values are mean 6 SEM;
units, mm; n 5 number of mice analyzed; 1/1, wild type; 2/2, homozygous null mutant.
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lower hypertrophic zone (Fig. 5 A k and l). In mutants, the
mineral distribution in trabeculae was irregular and patchy
(Fig. 5 A m and n), indicative of an altered deposition pat-
tern. Nevertheless, the chondrocyte morphology and struc-
ture of different zones appeared normal in the mutants
compared with the wild-type mice (data not shown). They
did not display signs of a shift in differentiation program
or of precocious necrosis or hypertrophy.
To visualize the fibrils better, proteoglycans and other
matrix materials were preferentially removed by fixing
samples in tannic acid. The elevated amount of granular
materials seen in the proliferating zone of RHT-fixed mu-
tant samples was not seen. However, a similar disorganiza-
tion of collagen fibrils in the proliferating zone and atypi-
cal distribution of matrix vesicles were still evident in
mutants (three 2/2 and three 1/1 mice studied) (Fig. 5 B
d and f). In addition the collagen fibrils appeared wavy
and short. Although these phenotypic consequences in the
mutant were not reported by Rosati et al. (1994), this may
be related to differences in the genetic background of the
mutant mice and the methodology of electron microscopic
examination. In their studies, the morphology of the pro-
liferating and resting zones of mutants were not examined.
Futhermore, their samples were fixed in tannic acid, and
therefore the abnormal distribution of proteoglycans
would not be apparent.
Figure 4. Altered trabecular morphology and organization in collagen X mutants. The proximal metaphyseal growth plate of the tibia
was sectioned longitudinally and the matrix materials were stained with toluidine blue. (A and B) 2-d; (C and D) 4-wk and (E and F)
8-wk wild-type (1/1, A, C, and E) and mutant (2/2, B, D, and F) female mice of 129/SvJ background are shown. In mutants, the trabec-
ular structure (arrowheads) appeared abnormal. Abbreviations: hy, hypertrophic chondrocytes; bm, bone marrow. Bar, 100 mm.
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Altered Bone Content and Coxa Vara in Col10a1 
Deficient Mice
In view of the importance of matrix vesicles in the miner-
alization process, we investigated whether the ultrastruc-
tural and bone trabecular changes were accompanied by
changes in bone content. The femurs of 2-d mutant and
wild-type mice were examined by contact microradiogra-
phy. These analyses revealed marked differences in the
Figure 5. Altered distribu-
tion of proteoglycans and
matrix vesicles in the growth
plates of collagen X mutants.
(A) Ultrastructure of the car-
tilage matrix of RHT-fixed
samples from wild-type (1/1)
and collagen X deficient (2/
2) mice. Matrix ultrastruc-
ture of resting (res, a–d), pro-
liferating (pro, e and f), up-
per hypertrophic (uhy, g–j),
lower hypertrophic (lhy, k
and l) zones of the growth
plate cartilage and trabecu-
lae (tb, m and n) of wild-type
(1/1) and collagen X defi-
cient (2/2) 2-d-old 129/SvJ
mice are shown. In the four
mutants studied, vesicles
(outlined arrowheads), of av-
erage 100-nm-diam and con-
taining electron-dense inclu-
sions, characteristic of matrix
vesicles, are more abundant
in the matrix of the resting
and proliferating zones, but
are fewer in the upper hyper-
trophic zone (see Table II).
Granular material (filled ar-
rowheads), with the typical
appearance of proteoglycans,
some of which adhering to
the surface of the collagen
fibrils (arrows), are found
dispersed in the matrix in all
zones in the wild-type. The
amount of these granular
materials are increased in the
mutant resting and prolifera-
tive zones (d and f) but re-
duced in the upper hyper-
trophic zone (j). Collagen
fibrils in the proliferating and
upper hypertrophic zones of
the mutant are abnormal but
are normal in the resting
zone. Signs of mineralization
in the form of calcified spic-
ules can be seen in the lower
hypertrophic zone (k and l)
and in the trabeculae at the chondrosseous junction (m and n). Distribution pattern of mineral deposits in trabeculae of mutant is
patchy compared to wild type. Bar, 200 nm. (B). Ultrastructure of the cartilage matrix of tannic acid–fixed samples from wild-type (1/1)
and collagen X deficient (2/2) 2-d 129/SvJ mice. The specimens were fixed in a fixative, containing tannic acid, which in contrast to
RHT fixative, would leach out proteoglycans. In the cartilage of the mutant mice, the membrane vesicles (outlined arrowheads) are
found in the resting (res) and proliferating (pro) zones (b and d), in addition to the upper hypertrophic zone (uhy) where the membrane
vesicles are normally compartmentalized (a, c, and e). The population of membrane vesicles in the upper hypertrophic zone of the mu-
tant cartilage is also significantly reduced (f). Removal of the proteoglycan content in the cartilage revealed more clearly the fibrillar or-
ganization. In the resting zone, the fibrils (arrows) in the mutant and wild-type specimens display similar morphology (a and b), but the
fibrils in the proliferating and upper hypertrophic zones of the mutant are more contorted and shorter in appearance (d and f). The ultra-
structural appearance of the matrix in the lower hypertrophic zone is similar between the wild type (g) and the mutant cartilage (h). Bar,
200 nm.
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Table II. Distribution of Matrix Vesicles in Different Tissue 
Compartments of the Growth Plate Cartilage of Limb Bones of 
Collagen X Deficient and Wild-Type Mice
Growth plate zone
Number of matrix vesicles/unit volume
1/1 (n) 2/2 (n)
Resting 0 (14) 20.5 63.5* (11)
Proliferating 0 (12) 22.9 6 4.1* (8)
Upper hypertrophic 18.9 6 1.8 (12) 11.5 6 1.7* (11)
*Significant difference (values at P , 0.05 by two-tailed Mann-Whitney U test) be-
tween 1/1, wild-type; 2/2, homozygous null mutant of 129/SvJ background; n 5
number of tissue fields studied; values are mean 6 SEM; unit volume 5 area of tissue
scored (3.2 mm2) X section thickness (0.1 mm) 5 0.32 mm3.
radiographic opacity of the trabecular bones of mutants.
There was reduced overall bone content in the femur of 2-d
129/SvJ mutants (Fig. 6, A and B; Table III). But in 4-wk
mutant femur, trabecular bone content was greater (Fig. 6,
C and D; Table III). In C57BL/6-129/SvJ hybrid mutants
bone content was decreased at 2 d but not at 4 wk (Table
III).
A common feature of SMCD patients is the develop-
ment of coxa vara which is clinically diagnosed as a reduc-
tion in the angle between the femoral neck and shaft, and
a concordent shortening of the femoral neck. The hip
joints of 13 wild-type and 10 collagen X deficient mice of
both C57/BL6-129Sv/J hybrid and 129/SvJ background
were examined radiographically (Fig. 6 I). When the angle
of the femur was compared between the mutant and wild-
type mice, without taking any consideration of the hand-
edness of the bone, only a slight reduction in the angle was
observed in the mutants. However, in three mutant mice,
the angle measurement clearly fell outside the normal
range expected from the wild type (Fig. 6, F and H). More-
over, when the left and right femurs were analyzed sepa-
rately, statistically, there was a significant reduction in the
angle for the right femur of the mutant mice (Mann-Whit-
ney U test, P , 0.05; Fig. 6 I). Our study thus revealed a
previously unnoticed unilateral coxa vara in some mice
that lack collagen X.
Discussion
Skeletogenesis by endochondral ossification is a complex
process involving coordinated events of signaling through
various appropriate growth factors leading to the correct
cellular development in the growth plate; synthesis of the
appropriate matrix components; formation of a scaffold
for initial and progressive deposition of mineral within the
matrix; production of catabolic factors for removal and re-
modeling of the matrix—all in a precisely timed and spa-
tially organized manner. Although details of the process of
endochondral ossification are well described, our under-
standing of the molecular factors and mechanisms which
Figure 6. Altered bone content and incidence of coxa vara in col-
lagen X mutants. (A–D) Microradiographs of the femurs of 2-d
(A and B) and 4-wk (C and D) wild-type (1/1, A and C) and mu-
tant (2/2, B and D) female mice of 129/SvJ background. The
opacity of the bony region (white in X-ray image) correlates with
the amount of radiographically opaque bone materials. The bone
content was measured by densitometry at the sites indicated on
the wild-type radiographs and the data are summarized in the Ta-
ble III. Single-headed arrows in B and D indicate orientation
proximal-distal. Abbreviations for bony landmarks: h, distal head
(articular condyle); j, knee joint, m, marrow cavity; n, neck; t,
tibia; s, shaft. Bar, 0.5 mm. (E–H) Radiographic study of the an-
gle of the femur head of wild-type (1/1, E and G) and mutant
(2/2, F and H) mice at 13–14 months (E and F) and 20–22
months (G and H). A decrease in the angle between the neck (fn)
and the shaft (fs) of the femur (coxa vara) is observed at both
ages. There is always a significant foreshortening of the length of
the neck of the femur of the mutant mice shown in F and H. Bar,
1 mm. (I) Measurements of the angle of the head of the left and
right femur of the wild-type and mutant mice at various postnatal
ages. Significant unilateral (right) coxa vara, showing varus angu-
lation was found in some collagen X deficient mutants (see Results).
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regulate and influence the mineralization process and con-
tribute to the unique architecture of bone is limited (Erle-
bacher et al., 1995). The molecular bases underlying the
pathology of many forms of chondrodysplasia are also
poorly understood (Horton and Hecht, 1993).
Despite the correlation between collagen X expression
and endochondral ossification, a definition of its exact role
has proved elusive. Also difficult to reconcile and explain
has been the apparently contradictory consequences of
mutations in the genes which result in collagen X defi-
ciency, in human, and in mouse. Biochemical and cell
transfection studies support the suggestion that in human
SMCD, mutations in the NC1 domain cause depletion of
collagen X because of a failure in assembly and secretion
(Chan et al., 1995, 1996). Yet mice lacking collagen X have
been reported to appear normal and do not develop
SMCD (Rosati et al., 1994).
In this study we have shown that collagen X deficiency
in mice does have phenotypic consequences which partly
resemble SMCD, reducing the apparent discrepancy in
phenotype between human and mouse. Intriguingly, the
major impact of collagen X deficiency does not lie in its
site of expression, the hypertrophic zone, but rather af-
fects other zones of the growth plate and bone. We have
found that the consequence of loss of collagen X in mutant
mice is a major change in the distribution of matrix materi-
als within the epiphyseal cartilage. Other features of col-
lagen X deficiency are a significant reduction in the thick-
ness of the resting zone and articular cartilage, an altered
trabecular structure, and the bone content of femur bone.
In particular, we find that collagen X deficient mice do de-
velop coxa vara, one of phenotypic changes common in
human SMCD. Notably, the genetic background of the
mice is involved in the variability of some of the pheno-
typic consequences of the Col10a1 mutation. An inbred
background gave higher degree of penetrance and expres-
sivity of the phenotype as shown in the trabecular mor-
phological alteration, bone content measurement, and the
occurence of coxa vara in the mutants. Variability of phe-
notypes has been reported previously in other “knock-
out” studies (Liu et al., 1993; Ramírez-Solis et al., 1993),
but it is still difficult to assess the cause for this.
A Hypothesis for the Function of Collagen X
Our data suggest that the underlying cause of these pheno-
typic changes could be related to the abnormal distribu-
tion of proteoglycans and matrix vesicles to nonhyper-
trophic regions of epiphyseal cartilage in the absence of
collagen X. This altered distribution of matrix components
may have arisen by diffusion from the hypertrophic zone
or by displacement as the result of forces generated by
rapid endochondral bone growth and initial perambula-
tion. The changes in distribution of matrix components
would alter the physical properties of the resting zone of
growth plate cartilage and therefore its resilience to com-
pression. In older animals articular cartilage thickness is
reduced. Since collagen X is present in articular cartilage
of wild-type mice at 4 wk and older (Cheah, K.S.E., un-
published data), these changes could be caused by the
altered matrix composition in mutants. The persistent car-
tilaginous matrix in mutant trabeculae may reflect a differ-
ent rate of replacement of an altered cartilage matrix by
bone, in the absence of collagen X.
The alterations in bone content seen in mutants may be
secondary effects due to the redistribution of matrix com-
ponents in the absence of collagen X which results in a dif-
ferent pattern and regulation of the mineralization and re-
modeling process. The regulation of mineralization in
cartilage and bone is complex and poorly understood, but
collagens, proteoglycans, and matrix molecules are clearly
involved in this process (Boskey, 1992). Matrix-mineral in-
teractions within the hypertrophic zone of growth plate also
regulate the size and type of hydroxyapatite crystal forma-
tion in bone during endochondral ossification (Boskey,
1992). Apart from their contribution to matrix structure in
providing resilience under compressive force, proteoglycans
are not initiators of mineralization but are proposed to
play a role in mineralization by regulating hydroxyapatite
growth and orientation (Boskey, 1992; Hunter, 1991).
Table III. Measurements of Radiographic Opacity in Collagen X Deficient and Wild-Type Mice
Bone and age (pp) Col10a1 genotype and genetic background
129/SvJ (n) C57BL/6-129/SvJ (n)
2 d 1/1 (7) 2/2 (7) 1/1 (8) 2/2 (8)
Femur shaft 110.54 6 7.87 75.88 6 7.42* 80.48 6 3.6 51.73 6 6.43*
(P 5 0.026) (P 5 0.022)
4 wk 1/1 (5) 2/2 (10) 1/1 (13) 2/2 (13)
Femur head 141.66 6 13.57 199.74 6 5.83* 163.42 6 4.97 161.76 6 6.11
(P 5 0.028)
Shaft-head junction 116.72 6 22.81 169.42 6 8.11‡ 140.09 6 6.57 152.42 6 5.03
(P 5 0.058)
Femur shaft 12.07 6 5.32 35.66 6 8.12§ 12.57 6 2.45 10.56 6 2.04
(P 5 0.054)
The mineral content of the femur (expressed as the radiographic opacity) of mutant mice of 129/SvJ and C57BL/6-129/SvJ hybrid background were measured. Values represent
mean 6 SEM, unit in pixels; n 5 number of mice analyzed; pp, postpartum; 1/1, wild-type; 2/2, homozygous null mutant.
*Significant difference, P , 0.05 by K-S test;
‡ and §, P values marginally significant by K-S test.
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Matrix vesicles are extracellular, cell-derived, membrane-
bound microstructures containing mineral and alkaline
phosphatase. These vesicles are abundant in the inter-ter-
ritorial matrix in the upper hypertrophic zone and are pro-
posed to be the initial nucleational foci for mineralization
(Anderson, 1995). Matrix vesicles in the growth plate are
associated with proteoglycans (Wu et al., 1991) and can
bind to both collagens II and X (Kirsch and Wuthier, 1994;
Kirsch et al., 1994). It has also been shown that the interac-
tion between collagen II and X with matrix vesicles acti-
vates the influx of Ca11 into matrix vesicles suggesting a
regulatory role of collagen X in mineralization (Kirsch and
Wuthier, 1994; Kirsch et al., 1994).
Thus, the observed abnormal trabecular structure, re-
tention of cartilaginous matrix within trabeculae and al-
tered bone content in the mutant may reflect perturbation
of both the normal patterns of matrix remodeling and min-
eral deposition caused by the altered distribution of matrix
vesicles and proteoglycans within the growth plate in the
absence of collagen X. Bone mineralization is thought to
occur in two phases, initially via matrix vesicles for the for-
mation of hydroxyapatite, and later through nucleation at
collagen fibrils for the proliferation of mineral crystal
within the extracelluar matrix (Anderson, 1995; Christof-
ferson and Landis, 1991). The increased bone content ob-
served at 4 wk may be a consequence of improperly regu-
lated secondary mineralization caused by the altered
matrix composition of the cartilaginous remnants in bone.
Taking all the data together, we hypothesize that col-
lagen X is important for the compartmentalization of ma-
trix components to the hypertrophic zone of growth carti-
lage, providing the proper environment for mineralization
and bone remodeling. The hexagonal lattice structure pro-
posed for collagen X (Kwan et al., 1991) and its affinity for
proteoglycans (Chen et al., 1992) and collagen fibrils (Poole
and Pidoux, 1989; Schmid and Linsenmayer, 1990) would
be consistent with a role in compartmentalization. Col-
lagen X may act as a pericellular network retaining or
trapping the necessary types and amounts of matrix com-
ponents, including the matrix vesicles and proteoglycans in
the correct location of the hypertrophic zone of the growth
plate, promoting initiation of normal mineralization. Thus,
in the absence of collagen X, there is wider spread distri-
bution of matrix components normally restricted to, or
more concentrated in, the hypertrophic zone. As second-
ary consequences, this improper distribution of matrix
molecules alters the structure of newly formed bone as
well as the physical properties of cartilage, resulting in
compression and deformation of parts of the growth plate.
This hypothesis would reconcile the previously proposed
differing views of the function of collagen X as a structural
molecule providing support and as a regulator of mineral-
ization.
Implications for the Molecular Mechanisms Underlying 
SMCD and Collagen X Mutations in Humans
With the increasing use of gene targeting in the mouse to
produce models for understanding the molecular mecha-
nisms underlying human disease, it has become increas-
ingly important to assess how closely phenotypic conse-
quences of mutations in mouse and man resemble each
other. Our results show collagen X deficiency in mice does
have phenotypic consequences which partly resemble
SMCD, such as persistence of cartilage in trabecular bone
and abnormalities in mineralization. The development of
coxa vara is thought to be caused by a weakness of the
growth plate in the metaphyses. The alterations in bone
content and trabecular stucture in the mouse mutants may
result in reduced strength of the bone against compressive
force later in life and cause the onset of the coxa vara. The
identification of coxa vara in the mutants, albeit at a later
stage of onset than in human, suggests that collagen X de-
ficiency does lead to weakening of the growth plate which
would be consistent with a supportive role for the protein.
In addition the data provides in vivo evidence supporting
reduced collagen X levels as the cause of SMCD pheno-
type (Warman et al., 1993; Chan et al., 1995). In human
metaphyseal chondrodysplasias, the extent of varus angu-
lation is rarely equal on both sides. The varying incidence
of coxa vara in the mouse mutants resembles the wide
range of abnormality found in human SMCD which is, in
any event, a relatively mild form of chondrodysplasia re-
viewed by Horton and Hecht (1993) and Lachman et al.
(1988).
The reason for the late onset of coxa vara and the rela-
tively milder phenotypic changes in collagen X mutant
mice is not fully understood. The late onset of the defect in
the mutant mice compared with the SMCD patients may
be related to the differences in loading of the growth plate
between man, a biped and mouse, a quadriped. However,
the collagen X content in SMCD growth plates has not
been determined. In addition it is not known if synthesiz-
ing abnormal a1(X) collagen chains which cannot assem-
ble, has additional effects on hypertrophic chondrocytes,
affecting their growth. It would therefore be important to
compare the phenotypic consequences of the null with a
SMCD mutation in mice.
An important issue raised is the relative mildness of
phenotype in the null mutants compared with the SMD-
like transgenic mice. Depletion of collagen X molecules
caused by dominant interference with the normal assem-
bly of the mouse protein by truncated chicken a1(X)
chains has been proposed to cause the SMD-like pheno-
type in transgenic mice (Jacenko et al., 1993b), including
compression of hypertrophic growth plate cartilage and a
decrease in newly formed trabecular bone. An alternative
explanation of the SMD-like phenotype is that the trun-
cated chicken a1(X) collagen chains cause a dominant nega-
tive effect because of the deposition of abnormal collagen X
in the matrix. The ability of a1(X) chains with internal de-
letions within the helix to assemble with normal chains as
heterotrimers and be secreted, support the latter explana-
tion (Chan et al., 1996). It is notable that the changes in
trabecular structure observed in SMD-like transgenic mice
(Jacenko et al., 1993b) were similar but more severe than
in the collagen X null mutants. Our results suggest that dif-
ferent phenotypes of the null mutants and the SMD-like
transgenic mice probably reflect differing severity of out-
come of mutations resulting in loss vs gain of function.
Our data has yielded new insight into collagen X func-
tion. Questions remaining and currently being addressed,
are the longer-term effects of the early matrix changes on
susceptibility to osteoarthritis, bone remodeling, and frac-
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ture repair since collagen X was shown to be upregulated
in osteoarthritis (Von der Mark et al., 1992; Aigner et al.,
1993; Hoyland et al., 1991) and transiently expressed in
bone callus during fracture healing (Grant et al., 1987;
Topping et al., 1994). Since all SMCD mutations found
have been in the COOH-terminal noncollagenous domain
reviewed in Chan et al. (1996), an additional question
would be whether alterations elsewhere in the molecule
may cause a different phenotype.
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